Cargando…

Recent developments in topoisomerase-targeted cancer chemotherapy

The DNA topoisomerase enzymes are essential to cell function and are found ubiquitously in all domains of life. The various topoisomerase enzymes perform a wide range of functions related to the maintenance of DNA topology during DNA replication, and transcription are the targets of a wide range of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hevener, KirkE., Verstak, Tatsiana A., Lutat, Katie E., Riggsbee, Daniel L., Mooney, Jeremiah W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251812/ https://www.ncbi.nlm.nih.gov/pubmed/30505655 http://dx.doi.org/10.1016/j.apsb.2018.07.008

Ejemplares similares

Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors
por: Jang, Jung Yoon, et al.
Publicado: (2023)

Topoisomerases and cancer chemotherapy: recent advances and unanswered questions
por: Bjornsti, Mary-Ann, et al.
Publicado: (2019)

Targeting DNA Topoisomerase II in Antifungal Chemotherapy
por: Kondaka, Kavya, et al.
Publicado: (2022)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
por: Bai, Yang, et al.
Publicado: (2016)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006)

Targeting DNA topoisomerases: past & future
por: Gmeiner, William H., et al.
Publicado: (2021)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
por: Gilbert, D C, et al.
Publicado: (2012)

Recent Developments of Systemic Chemotherapy for Gastric Cancer
por: Arai, Hiroyuki, et al.
Publicado: (2020)

Prognostic Values of Filamin-A Status for Topoisomerase II Poison Chemotherapy
por: Yue, Jingyin, et al.
Publicado: (2012)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
por: JÃ¤rvinen, T. A., et al.
Publicado: (1998)

965. The Efficacy of Oral Β-lactam Antibiotics as Step-down Therapy for Acute Pyelonephritis
por: Hobbs, Athena L V, et al.
Publicado: (2019)

Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
por: Lee, Yu-Chieh, et al.
Publicado: (2015)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022)

Topoisomerase gets around
por: Dove, Alan W.
Publicado: (2002)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

PROGNOSTIC VALUE OF TOPOISOMERASE 2-ALPHA AND B-MYB IN EARLY BREAST CANCER TREATED WITH ADJUVANT CHEMOTHERAPY
por: Radmilović Varga, Ljubica, et al.
Publicado: (2021)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

Type IA Topoisomerases as Targets for Infectious Disease Treatments
por: Seddek, Ahmed, et al.
Publicado: (2021)

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
por: Xu, Huanli, et al.
Publicado: (2016)

Biomodulation by Hyperthermia of Topoisomerase II‐Targeting Drugs in Human Colorectal Cancer Cells
por: Hirohashi, Yoshimi, et al.
Publicado: (1995)

Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review
por: Greco, Giulia, et al.
Publicado: (2022)

Recent advances in tumor-targeting chemotherapy drugs
por: Ojima, Iwao
Publicado: (2021)

DNA Topoisomerases Participate in Fragility of the Oncogene RET
por: Dillon, Laura W., et al.
Publicado: (2013)

Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements
por: Takahashi, Diane T, et al.
Publicado: (2019)

Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
por: Baek, Sun Kyung, et al.
Publicado: (2019)

Topoisomerase IV can functionally replace all type 1A topoisomerases in Bacillus subtilis
por: Reuß, Daniel R, et al.
Publicado: (2019)

A statistical framework to evaluate virtual screening
por: Zhao, Wei, et al.
Publicado: (2009)

Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer
por: Yan, Shi, et al.
Publicado: (2010)

Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer
por: Lv, Chunxin, et al.
Publicado: (2018)

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a(-/- )mutants
por: Sapetto-Rebow, Beata, et al.
Publicado: (2011)

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues
por: Pfister, Thomas D., et al.
Publicado: (2012)

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
por: Miura, Yosuke, et al.
Publicado: (2017)

Correction to ‘Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements’
Publicado: (2022)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

Bacterial topoisomerase I as a target for discovery of antibacterial compounds
por: Tse-Dinh, Yuk-Ching
Publicado: (2009)

Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II
por: Lee, Ka C., et al.
Publicado: (2016)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_43uvk2ut0nmiho25r4eemdgjb2